Heart failure happens when your heart is weak and cannot pump enough blood to your lungs and the rest of your body.
A fast heartbeat; shortness of breath; ongoing coughing or wheezing; feeling dizzy, weak, or tired; or swelling of the feet or legs. These are not the only symptoms of heart failure.
Looking for a conversation starter to help you talk to your doctor about treatment? This handy guide includes some questions to bring to your next appointment, so you and your doctor can determine if VERQUVO is right for you.
Not an actual patient.
Hospitalization
About 1 million people in the United States are hospitalized every year with heart failure.
A heart failure hospitalization may increase your chances of going back to the hospital. About 56% of patients hospitalized (or who receive IV medicine) due to increased heart failure symptoms return to the hospital within 30 days.*
* From a study of heart failure patients in the National PINNACLE Registry, where 1,851 patients with ejection fraction (amount of blood pumped with each heartbeat) less than or equal to 45% had increased symptoms of heart failure that required hospitalization or IV medicine.
VERQUVO is the first and only FDA-approved medicine studied specifically in patients who had a recent heart failure hospitalization or received IV medicine for their heart failure.‡
• Over 5,000 patients with heart failure participated
‡Patients had been hospitalized within the previous 6 months or had received IV medicine for heart failure within the previous 3 months
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent.
What is VERQUVO?
VERQUVO is a prescription medicine used in adults who are having symptoms of
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.
IMPORTANT SAFETY INFORMATION
VERQUVO may cause birth defects if taken during pregnancy.
VERQUVO may cause birth defects if taken during pregnancy.
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.
VERQUVO may cause birth defects if taken during pregnancy.
Do not take VERQUVO if you:
Before taking VERQUVO, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take. Certain other medicines may affect how VERQUVO works.
The most common side effects of VERQUVO include:
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the accompanying Medication Guide for VERQUVO, including the information about birth defects if taken during pregnancy, and discuss it with your doctor. The physician Prescribing Information also is available.